Lexaria Bioscience (LEXX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lexaria Bioscience has announced a $5 million registered direct offering, pricing its shares at-the-market under Nasdaq rules. The company will also issue unregistered warrants for additional shares, with proceeds intended for working capital and corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.